Most studies show the loss of nicotinic receptors in AD patients, especially the α7 subtype (α7nAChR) that contributes to the modulation of long-term memory formation (Hampel et al., 2018; Alkadhi, 2021). Here, CHRNA7 is linked to Alzheimer disease.